APASL consensus statements and recommendation on treatment of hepatitis C

Masao Omata; Tatsuo Kanda; Lai Wei; Ming Lung Yu; Wang Long Chuang; Alaaeldin Ibrahim; Cosmas Rinaldi Adithya Lesmana; Jose Sollano; Manoj Kumar; Ankur Jindal; Barjesh Chander Sharma; Saeed S. Hamid; A. Kadir Dokmeci; Mamun-Al-Mahtab; Geofferey W. McCaughan; Jafri Wasim; Darrell H.G. Crawford; Jia Horng Kao; Osamu Yokosuka; George K.K. Lau; Shiv Kumar Sarin

doi:10.1007/s12072-016-9717-6

APASL consensus statements and recommendation on treatment of hepatitis C

Masao Omata, Tatsuo Kanda, Lai Wei, Ming Lung Yu, Wang Long Chuang, Alaaeldin Ibrahim, Cosmas Rinaldi Adithya Lesmana, Jose Sollano, Manoj Kumar, Ankur Jindal, Barjesh Chander Sharma, Saeed S. Hamid, A. Kadir Dokmeci, Mamun-Al-Mahtab, Geofferey W. McCaughan, Jafri Wasim, Darrell H.G. Crawford, Jia Horng Kao, Osamu Yokosuka, George K.K. LauShiv Kumar Sarin

Department of Medicine, Medical College, Pakistan

Research output: Contribution to journal › Review article › peer-review

197 Citations (Scopus)

Abstract

The Asian-Pacific Association for the Study of the Liver (APASL) convened an international working party on the “APASL consensus statements and recommendation on management of hepatitis C” in March, 2015, in order to revise “APASL consensus statements and management algorithms for hepatitis C virus infection (Hepatol Int 6:409–435, 2012)”. The working party consisted of expert hepatologists from the Asian-Pacific region gathered at Istanbul Congress Center, Istanbul, Turkey on 13 March 2015. New data were presented, discussed and debated to draft a revision. Participants of the consensus meeting assessed the quality of cited studies. Finalized recommendations on treatment of hepatitis C are presented in this review.

Original language	English
Pages (from-to)	702-726
Number of pages	25
Journal	Hepatology International
Volume	10
Issue number	5
DOIs	https://doi.org/10.1007/s12072-016-9717-6
Publication status	Published - 1 Sept 2016

Keywords

APASL
DAAs
HCV
Interferon-free
Turkey

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s12072-016-9717-6

Cite this

Omata, M., Kanda, T., Wei, L., Yu, M. L., Chuang, W. L., Ibrahim, A., Lesmana, C. R. A., Sollano, J., Kumar, M., Jindal, A., Sharma, B. C., Hamid, S. S., Dokmeci, A. K., Mamun-Al-Mahtab, McCaughan, G. W., Wasim, J., Crawford, D. H. G., Kao, J. H., Yokosuka, O., ... Sarin, S. K. (2016). APASL consensus statements and recommendation on treatment of hepatitis C. Hepatology International, 10(5), 702-726. https://doi.org/10.1007/s12072-016-9717-6

@article{9e8bcf7bcf984873a5c3b00dfb68eb13,

title = "APASL consensus statements and recommendation on treatment of hepatitis C",

abstract = "The Asian-Pacific Association for the Study of the Liver (APASL) convened an international working party on the “APASL consensus statements and recommendation on management of hepatitis C” in March, 2015, in order to revise “APASL consensus statements and management algorithms for hepatitis C virus infection (Hepatol Int 6:409–435, 2012)”. The working party consisted of expert hepatologists from the Asian-Pacific region gathered at Istanbul Congress Center, Istanbul, Turkey on 13 March 2015. New data were presented, discussed and debated to draft a revision. Participants of the consensus meeting assessed the quality of cited studies. Finalized recommendations on treatment of hepatitis C are presented in this review.",

keywords = "APASL, DAAs, HCV, Interferon-free, Turkey",

author = "Masao Omata and Tatsuo Kanda and Lai Wei and Yu, {Ming Lung} and Chuang, {Wang Long} and Alaaeldin Ibrahim and Lesmana, {Cosmas Rinaldi Adithya} and Jose Sollano and Manoj Kumar and Ankur Jindal and Sharma, {Barjesh Chander} and Hamid, {Saeed S.} and Dokmeci, {A. Kadir} and Mamun-Al-Mahtab and McCaughan, {Geofferey W.} and Jafri Wasim and Crawford, {Darrell H.G.} and Kao, {Jia Horng} and Osamu Yokosuka and Lau, {George K.K.} and Sarin, {Shiv Kumar}",

note = "Publisher Copyright: {\textcopyright} 2016, The Author(s).",

year = "2016",

month = sep,

day = "1",

doi = "10.1007/s12072-016-9717-6",

language = "English",

volume = "10",

pages = "702--726",

journal = "Hepatology International",

issn = "1936-0533",

publisher = "Springer New York",

number = "5",

}

Omata, M, Kanda, T, Wei, L, Yu, ML, Chuang, WL, Ibrahim, A, Lesmana, CRA, Sollano, J, Kumar, M, Jindal, A, Sharma, BC, Hamid, SS, Dokmeci, AK, Mamun-Al-Mahtab, McCaughan, GW, Wasim, J, Crawford, DHG, Kao, JH, Yokosuka, O, Lau, GKK & Sarin, SK 2016, 'APASL consensus statements and recommendation on treatment of hepatitis C', Hepatology International, vol. 10, no. 5, pp. 702-726. https://doi.org/10.1007/s12072-016-9717-6

TY - JOUR

T1 - APASL consensus statements and recommendation on treatment of hepatitis C

AU - Omata, Masao

AU - Kanda, Tatsuo

AU - Wei, Lai

AU - Yu, Ming Lung

AU - Chuang, Wang Long

AU - Ibrahim, Alaaeldin

AU - Lesmana, Cosmas Rinaldi Adithya

AU - Sollano, Jose

AU - Kumar, Manoj

AU - Jindal, Ankur

AU - Sharma, Barjesh Chander

AU - Hamid, Saeed S.

AU - Dokmeci, A. Kadir

AU - Mamun-Al-Mahtab,

AU - McCaughan, Geofferey W.

AU - Wasim, Jafri

AU - Crawford, Darrell H.G.

AU - Kao, Jia Horng

AU - Yokosuka, Osamu

AU - Lau, George K.K.

AU - Sarin, Shiv Kumar

PY - 2016/9/1

Y1 - 2016/9/1

N2 - The Asian-Pacific Association for the Study of the Liver (APASL) convened an international working party on the “APASL consensus statements and recommendation on management of hepatitis C” in March, 2015, in order to revise “APASL consensus statements and management algorithms for hepatitis C virus infection (Hepatol Int 6:409–435, 2012)”. The working party consisted of expert hepatologists from the Asian-Pacific region gathered at Istanbul Congress Center, Istanbul, Turkey on 13 March 2015. New data were presented, discussed and debated to draft a revision. Participants of the consensus meeting assessed the quality of cited studies. Finalized recommendations on treatment of hepatitis C are presented in this review.

AB - The Asian-Pacific Association for the Study of the Liver (APASL) convened an international working party on the “APASL consensus statements and recommendation on management of hepatitis C” in March, 2015, in order to revise “APASL consensus statements and management algorithms for hepatitis C virus infection (Hepatol Int 6:409–435, 2012)”. The working party consisted of expert hepatologists from the Asian-Pacific region gathered at Istanbul Congress Center, Istanbul, Turkey on 13 March 2015. New data were presented, discussed and debated to draft a revision. Participants of the consensus meeting assessed the quality of cited studies. Finalized recommendations on treatment of hepatitis C are presented in this review.

KW - APASL

KW - DAAs

KW - HCV

KW - Interferon-free

KW - Turkey

UR - http://www.scopus.com/inward/record.url?scp=84964691124&partnerID=8YFLogxK

U2 - 10.1007/s12072-016-9717-6

DO - 10.1007/s12072-016-9717-6

M3 - Review article

C2 - 27130427

AN - SCOPUS:84964691124

SN - 1936-0533

VL - 10

SP - 702

EP - 726

JO - Hepatology International

JF - Hepatology International

IS - 5

ER -

APASL consensus statements and recommendation on treatment of hepatitis C

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this